P113 is a merozoite surface protein that binds the N terminus of Plasmodium falciparum RH5

Nature Communications

Volumn 8, Issue , 2017, Pages

  Galaway, Francis ^a   Drought, Laura G ^a   Fala, Maria ^a   Cross, Nadia ^a   Kemp, Alison C ^a   Rayner, Julian C ^a   Wright, Gavin J ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MEMBRANE PROTEIN; P113 PROTEIN; PROTOZOAL PROTEIN; RH5 ANTIBODY; UNCLASSIFIED DRUG; CARRIER PROTEIN; MALARIA VACCINE; PARASITE ANTIGEN; PROTEIN BINDING; PROTOZOON ANTIBODY; RH5 PROTEIN, PLASMODIUM FALCIPARUM;

ANTIBODY; BLOOD; CELLS AND CELL COMPONENTS; PARASITE; PATHOGENICITY; PROTEIN; PROTOZOAN; RECOMBINATION; VACCINE;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PLASMODIUM FALCIPARUM; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INTERACTION ASSAY; PROTEIN PROTEIN INTERACTION; ANIMAL; ERYTHROCYTE; HEK293 CELL LINE; IMMUNOLOGY; MALARIA FALCIPARUM; MEROZOITE; METABOLISM; PARASITOLOGY; PHYSIOLOGY;

PLASMODIUM FALCIPARUM;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CARRIER PROTEINS; ERYTHROCYTES; HEK293 CELLS; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; MEMBRANE PROTEINS; MEROZOITES; PLASMODIUM FALCIPARUM; PROTEIN BINDING; PROTOZOAN PROTEINS;

EID: 85012118948     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms14333     Document Type: Article

References (47)

1. Murray, C. J. et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379, 413-431 (2012).
2. Cowman, A. F. & Crabb, B. S. Invasion of red blood cells by malaria parasites. Cell 124, 755-766 (2006).
3. Cowman, A. F., Berry, D. & Baum, J. The cellular and molecular basis for malaria parasite invasion of the human red blood cell. J. Cell Biol. 198, 961-971 (2012).
4. Weiss, G. E. et al. Revealing the sequence and resulting cellular morphology of receptor-ligand interactions during Plasmodium falciparum invasion of erythrocytes. PLoS Pathog. 11, e1004670 (2015).
5. Hadley, T. J. Invasion of erythrocytes by malaria parasites: a cellular and molecular overview. Annu. Rev. Microbiol. 40, 451-477 (1986).
6. Gilson, P. R. & Crabb, B. S. Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites. Int. J. Parasitol. 39, 91-96 (2009).
7. Ord, R. L., Rodriguez, M. & Lobo, C. A. Malaria invasion ligand RH5 and its prime candidacy in blood-stage malaria vaccine design. Hum. Vaccines Immunother. 11, 1465-1473 (2015).
8. Baum, J. et al. Reticulocyte-binding protein homologue 5 - an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum. Int. J. Parasitol. 39, 371-380 (2009).
9. Crosnier, C. et al. Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature 480, 534-537 (2011).
10. Manske, M. et al. Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature 487, 375-379 (2012).
11. Douglas, A. D. et al. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat. Commun. 2, 601 (2011).
12. Ord, R. L. et al. Targeting sialic acid dependent and independent pathways of invasion in Plasmodium falciparum. PLoS ONE 7, e30251 (2012).
13. Bustamante, L. Y. et al. A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants. Vaccine 31, 373-379 (2013).
14. Reddy, K. S. et al. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent straintranscending parasite-neutralizing antibodies. Infect. Immun. 82, 152-164 (2014).
15. Douglas, A. D. et al. A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in Aotus monkeys. Cell Host Microbe 17, 130-139 (2015).
16. Chen, L. et al. An EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparum. PLoS Pathog. 7, e1002199 (2011).
17. Douglas, A. D. et al. Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5. J. Immunol. 192, 245-258 (2014).
18. Ord, R. L. et al. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein. Malar. J. 13, 326 (2014).
19. Wright, K. E. et al. Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies. Nature 515, 427-430 (2014).
20. Chen, L. et al. Crystal structure of PfRh5, an essential P. falciparum ligand for invasion of human erythrocytes. Elife 3, e04187 (2014).
21. Reddy, K. S. et al. Multiprotein complex between the GPI-anchored CyRPA with PfRH5 and PfRipr is crucial for Plasmodium falciparum erythrocyte invasion. Proc. Natl Acad. Sci. USA 112, 1179-1184 (2015).
22. Dreyer, A. M. et al. Passive immunoprotection of Plasmodium falciparuminfected mice designates the CyRPA as candidate malaria vaccine antigen. J. Immunol. 188, 6225-6237 (2012).
23. Bushell, K. M., Sollner, C., Schuster-Boeckler, B., Bateman, A. & Wright, G. J. Large-scale screening for novel low-affinity extracellular protein interactions. Genome Res. 18, 622-630 (2008).
24. Crosnier, C. et al. A library of functional recombinant cell-surface and secreted P. falciparum merozoite proteins. Mol. Cell Proteomics 12, 3976-3986 (2013).
25. Zenonos, Z. A., Rayner, J. C. & Wright, G. J. Towards a comprehensive Plasmodium falciparum merozoite cell surface and secreted recombinant protein library. Malar. J. 13, 93 (2014).
26. Sanders, P. R. et al. Distinct protein classes including novel merozoite surface antigens in Raft-like membranes of Plasmodium falciparum. J. Biol. Chem. 280, 40169-40176 (2005).
27. Sanders, P. R. et al. Identification of protein complexes in detergent-resistant membranes of Plasmodium falciparum schizonts. Mol. Biochem. Parasitol. 154, 148-157 (2007).
28. Florens, L. et al. A proteomic view of the Plasmodium falciparum life cycle. Nature 419, 520-526 (2002).
29. Silvestrini, F. et al. Protein export marks the early phase of gametocytogenesis of the human malaria parasite Plasmodium falciparum. Mol. Cell Proteomics 9, 1437-1448 (2010).
30. Imboumy-Limoukou, R. K. et al. Immunoglobulin response to the low polymorphic Pf113 antigen in children from Lastoursville, South-East of Gabon. Acta Tropica 163, 149-156 (2016).
31. Silmon de Monerri, N. C. et al. Global identification of multiple substrates for Plasmodium falciparum SUB1, an essential malarial processing protease. Infect. Immun. 79, 1086-1097 (2011).
32. Wright, G. J. Signal initiation in biological systems: the properties and detection of transient extracellular protein interactions. Mol. Biosyst. 5, 1405-1412 (2009).
33. Lupas, A., Van Dyke, M. & Stock, J. Predicting coiled coils from protein sequences. Science 252, 1162-1164 (1991).
34. Gondeau, C. et al. The C-terminal domain of Plasmodium falciparum merozoite surface protein 3 self-assembles into alpha-helical coiled coil tetramer. Mol. Biochem. Parasitol. 165, 153-161 (2009).
35. Elliott, J. F. et al. Genes for Plasmodium falciparum surface antigens cloned by expression in COS cells. Proc. Natl Acad. Sci. USA 87, 6363-6367 (1990).
36. Volz, J. C. et al. Essential role of the PfRh5/PfRipr/CyRPA complex during Plasmodium falciparum invasion of erythrocytes. Cell Host Microbe 20, 1 (2016).
37. Liu, H. et al. Structure-based programming of lymph-node targeting in molecular vaccines. Nature 507, 519-522 (2014).
38. Gilson, P. R. et al. Identification and stoichiometry of glycosylphosphatidylinositol-anchored membrane proteins of the human malaria parasite Plasmodium falciparum. Mol. Cell Proteomics 5, 1286-1299 (2006).
39. Osier, F. H. et al. New antigens for a multicomponent blood-stage malaria vaccine. Sci. Transl. Med. 6, 247ra102 (2014).
40. Richards, J. S. et al. Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development. J. Immunol. 191, 795-809 (2013).
41. Offeddu, V., Rauch, M., Silvie, O. & Matuschewski, K. The Plasmodium protein P113 supports efficient sporozoite to liver stage conversion in vivo. Mol. Biochem. Parasitol. 193, 101-109 (2014).
42. Elsworth, B. et al. Proteomic analysis reveals novel proteins associated with the Plasmodium protein exporter PTEX and a loss of complex stability upon truncation of the core PTEX component, PTEX150. Cell Microbiol. 18, 1551-1569 (2016).
43. Loignon, M. et al. Stable high volumetric production of glycosylated human recombinant IFNalpha2b in HEK293 cells. BMC Biotechnol. 8, 65 (2008).
44. Kerr, J. S. & Wright, G. J. Avidity-based extracellular interaction screening (AVEXIS) for the scalable detection of low-affinity extracellular receptor-ligand interactions. J. Vis. Exp. 5, e3881 (2012).
45. Bartholdson, S. J. et al. Semaphorin-7A is an erythrocyte receptor for P. falciparum merozoite-specific TRAP homolog, MTRAP. PLoS Pathog. 8, e1003031 (2012).
46. van der Merwe, P. A. & Barclay, A. N. Analysis of cell-adhesion molecule interactions using surface plasmon resonance. Curr. Opin. Immunol. 8, 257-261 (1996).
47. Jones, M. L., Kitson, E. L. & Rayner, J. C. Plasmodium falciparum erythrocyte invasion: a conserved myosin associated complex. Mol. Biochem. Parasitol. 147, 74-84 (2006).